Tribendimidine

Summary

Tribendimidine is a broad-spectrum anthelmintic agent developed in China, at the National Institute of Parasitic Diseases in Shanghai. It is a derivative of amidantel.[1]

Tribendimidine
Clinical data
ATC code
  • none
Identifiers
  • N,N-bis(4-(1-dimethylamino)ethylideneaminophenyl)-1,4
    -phenylene dimethylidyneamine
CAS Number
  • 115103-15-6 ☒N
PubChem CID
  • 3086564
ChemSpider
  • 2343161 checkY
UNII
  • YO6SOD6ZTJ
ChEMBL
  • ChEMBL427256 ☒N
CompTox Dashboard (EPA)
  • DTXSID50894077 Edit this at Wikidata
Chemical and physical data
FormulaC28H32N6
Molar mass452.606 g·mol−1
3D model (JSmol)
  • Interactive image
  • N(=C/c2ccc(\C=N\c1ccc(/N=C(/N(C)C)C)cc1)cc2)\c3ccc(\N=C(\N(C)C)C)cc3
  • InChI=1S/C28H32N6/c1-21(33(3)4)31-27-15-11-25(12-16-27)29-19-23-7-9-24(10-8-23)20-30-26-13-17-28(18-14-26)32-22(2)34(5)6/h7-20H,1-6H3/b29-19+,30-20+,31-21+,32-22+ checkY
  • Key:XOIOGKHKNQYULW-HTNNXBMUSA-N checkY
 ☒NcheckY (what is this?)  (verify)

In clinical trials, it was highly effective in treating ankylostomiasis, ascariasis and enterobiasis.[2] It is also effective against clonorchiasis.[3] However, animal studies suggest it is ineffective in treating Schistosoma mansoni or Fasciola hepatica disease.[1] The drug has also performed well in trials against opisthorchiasis, curing about 70% of cases.[4]

Tribendimidine is manufactured by Shandong Xinhua Pharmaceutical Company Limited in Zibo, Shandong, China. It was approved by the China Food and Drug Administration in 2007.[citation needed]

References edit

  1. ^ a b Keiser J, Shu-Hua X, Chollet J, Tanner M, Utzinger J (March 2007). "Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini". Antimicrobial Agents and Chemotherapy. 51 (3): 1096–1098. doi:10.1128/AAC.01366-06. PMC 1803157. PMID 17194822. Free full text.
  2. ^ Xiao SH, Hui-Ming W, Tanner M, Utzinger J, Chong W (April 2005). "Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China". Acta Tropica. 94 (1): 1–14. doi:10.1016/j.actatropica.2005.01.013. PMID 15777691.
  3. ^ Zhang H, Liu C, Zheng Q (December 2019). "Development and application of anthelminthic drugs in China". Acta Tropica. 200: 105181. doi:10.1016/j.actatropica.2019.105181. PMID 31542370.
  4. ^ Kelland K (2010-11-24). "New drug shows promise against Asian liver fluke". Reuters.